Chugai Pharmaceutical Co....

OTC: CHGCF · Real-Time Price · USD
39.99
-3.97 (-9.03%)
At close: Aug 15, 2025, 2:46 PM
43.96
9.93%
After-hours: Aug 13, 2025, 08:00 PM EDT

Chugai Pharmaceutical Cash Flow Statement

Financials in JPY. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
589.55B 325.47B 575.88B 470.37B
Depreciation & Amortization
n/a n/a 31.43B 30.87B
Stock-Based Compensation
n/a n/a n/a n/a
Other Working Capital
-28.84B 130.63B -183.31B -83.12B
Other Non-Cash Items
-113.1B -46.18B -179.89B -138.49B
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
-28.84B 130.63B -183.31B -83.12B
Operating Cash Flow
447.6B 409.93B 244.11B 279.63B
Capital Expenditures
-54.9B -74.26B -71.24B -72.87B
Cash Acquisitions
n/a n/a -7.29B 1.04B
Purchase of Investments
-948.55B -545.98B -519B -372.26B
Sales Maturities Of Investments
771.01B 546.96B 442.92B 325.03B
Other Investing Acitivies
1.1B 33.68B 8.61B 133M
Investing Cash Flow
-227.37B -37.29B -145.99B -118.93B
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
-10M n/a -5M -8M
Dividend Paid
-133.25B -131.59B -138.22B -98.64B
Other Financial Acitivies
-7.92B -7.95B -7.66B -8.76B
Financial Cash Flow
-141.01B -139.33B -145.64B -107.41B
Net Cash Flow
81.53B 236.5B -45.58B 55.42B
Free Cash Flow
392.7B 335.67B 172.87B 206.76B